Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coenzyme Q10 in children with idiopathic dilated cardiomyopathy
NCT02115581Phase 4Completed
- Sponsor
- University of Tehran
- Start
- Sep 2006
- Primary completion
- Mar 2008
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in idiopathic dilated cardiomyopathy (IDC), sponsored by University of Tehran. Primary endpoints: Left Ventricular Ejection Fraction at 6 months and Left Ventricular Filling Abnormality at 6 months. Started Sep 2006; status: completed.
02
Conditions
idiopathic dilated cardiomyopathy (IDC)
Beyond the preview
Go deeper on NCT02115581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02115581.